Postoperative outcomes after implantation of intraocular lenses in eyes with cataract and uveitis.
Despite advances in surgical technique and implant materials, cataract surgery in patients with uveitis is still a challenging procedure. We retrospectively evaluated postoperative outcomes of cataract surgery in 35 eyes of 29 patients with uveitis. Phacoemulsification with posterior chamber intraocular lens implantation was performed in all eyes. Postoperative evaluations were performed at day 2, and then at 7 days, 1, 3, and 6 months respectively. There were 16 males, and 13 females, aged 31 to 68 years. Follow-up ranged from 4 to 35 months. At final follow-up 33 eyes (94%) had an improvement in visual acuity compared with preoperative levels (p < 0,05). Giant cells were observed in the intraocular lens optic in 7 eyes (20%). Posterior capsule opacification occurred in 10 eyes (29%). Clinical cystoid macular edema was observed in 4 eyes, and 2 eyes required trabeculectomy with mitomycin C due to secondary glaucoma. Cataract surgery in patients with uveitis leads to successful visual results after correct surgical timing, and adequate anti-inflammatory therapy. There were no significant differences in the degree of inflammation after implantation of various types of intraocular lenses.
Mandić
Zdravko
Z
University Department of Ophthalmology, Clinical Hospital, Systers of Mercy, Zagreb, Croatia.
Petric
Ivanka
I
Bencić
Goran
G
Vatavuk
Zoran
Z
Bojić
Lovro
L
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002386:Cataract / Q000150:complications*; D005260:Female; D006801:Humans; D019654:Lens Implantation, Intraocular; D008297:Male; D008875:Middle Aged; D019990:Perioperative Care; D018918:Phacoemulsification; D012189:Retrospective Studies; D016896:Treatment Outcome; D014605:Uveitis / Q000150:complications* / Q000188:drug therapy
D000893:Anti-Inflammatory Agents